Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of ...

Please provide your email address to receive an email when new articles are posted on . Children recently diagnosed with type 1 diabetes had a higher C-peptide level at 78 weeks with teplizumab vs.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A single 14-day course of the monoclonal antibody ...

REDWOOD CITY, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced the presentation of ...